AR047797A1 - Formulacion solida de liberacion sostenida que comprende acetato de triptorelina - Google Patents
Formulacion solida de liberacion sostenida que comprende acetato de triptorelinaInfo
- Publication number
- AR047797A1 AR047797A1 ARP050100422A ARP050100422A AR047797A1 AR 047797 A1 AR047797 A1 AR 047797A1 AR P050100422 A ARP050100422 A AR P050100422A AR P050100422 A ARP050100422 A AR P050100422A AR 047797 A1 AR047797 A1 AR 047797A1
- Authority
- AR
- Argentina
- Prior art keywords
- triptorelin acetate
- formulation
- sustained release
- excipients
- acetate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000007787 solid Substances 0.000 title abstract 2
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 title 1
- 229960004824 triptorelin Drugs 0.000 title 1
- HPPONSCISKROOD-OYLNGHKZSA-N acetic acid;(2s)-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-[[(2s)-1-[(2s)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-y Chemical compound CC(O)=O.C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 HPPONSCISKROOD-OYLNGHKZSA-N 0.000 abstract 5
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 5
- 229960000434 triptorelin acetate Drugs 0.000 abstract 5
- 229920001577 copolymer Polymers 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 1
- 238000001125 extrusion Methods 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulacion solida de liberacion sostenida para administracion parenteral que comprende: a) acetato de triptorelina, y b) uno o más excipientes que comprenden un polímero o copolímero de ácidos láctico y/o glicolico o una mezcla de polímeros y/o copolímeros de ácidos láctico y/o glicolico, dicha formulacion contiene acetato de triptorelina en una proporcion del 10 a 99 % en peso relativa al peso total de la formulacion y se obtiene por un proceso que comprende el fundido de la mezcla de acetato de triptorelina con el excipiente o excipientes durante la fusion-extrusion de acetato de triptorelina con el excipiente o excipientes, siendo dicha formulacion de tal manera que libere el acetato de triptorelina durante un período de al menos una semana una vez administrada al paciente por vía parenteral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0401109A FR2865938B1 (fr) | 2004-02-05 | 2004-02-05 | Formulation retard solide comprenant de l'acetate de triptoreline |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047797A1 true AR047797A1 (es) | 2006-02-22 |
Family
ID=34778533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050100422A AR047797A1 (es) | 2004-02-05 | 2005-02-04 | Formulacion solida de liberacion sostenida que comprende acetato de triptorelina |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070031500A1 (es) |
EP (1) | EP1722820A1 (es) |
JP (1) | JP2007520533A (es) |
CN (1) | CN1913924B (es) |
AR (1) | AR047797A1 (es) |
BR (1) | BRPI0507326A (es) |
CA (1) | CA2554870A1 (es) |
FR (1) | FR2865938B1 (es) |
HK (1) | HK1101127A1 (es) |
IL (1) | IL176786A0 (es) |
MX (1) | MXPA06008617A (es) |
RU (1) | RU2399384C2 (es) |
TW (1) | TWI399224B (es) |
WO (1) | WO2005082418A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2540838C (en) | 2003-10-03 | 2014-12-16 | Thorn Bioscience, Llc | Process for the synchronization of ovulation for timed breeding without heat detection |
CA2688478C (en) * | 2007-06-06 | 2015-10-27 | Debio Recherche Pharmaceutique S.A. | Slow release pharmaceutical composition made of microparticles |
CN104906556A (zh) | 2009-04-23 | 2015-09-16 | Jbs联合动物健康二有限公司 | 用于同步授精时间的方法和组合物 |
EP2246063A1 (en) * | 2009-04-29 | 2010-11-03 | Ipsen Pharma S.A.S. | Sustained release formulations comprising GnRH analogues |
CN102048699B (zh) * | 2009-11-03 | 2012-11-07 | 长春金赛药业有限责任公司 | 一种注射用醋酸曲普瑞林的缓释微球的制备方法 |
WO2013083605A1 (en) * | 2011-12-05 | 2013-06-13 | Ferring Bv | Triptorelin pharmaceutical composition |
CN104994865A (zh) | 2012-11-28 | 2015-10-21 | 杰碧斯联合动物健康第二有限责任公司 | 用于同步小母猪的授精时间的方法 |
CN105267153B (zh) * | 2015-11-27 | 2018-05-11 | 上海苏豪逸明制药有限公司 | 一种曲普瑞林缓释微粒及其制备方法 |
CN105878174B (zh) * | 2016-04-26 | 2021-06-29 | 广州帝奇医药技术有限公司 | 一种固体分散体及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH679207A5 (es) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
GB2246514B (en) * | 1990-08-01 | 1993-12-15 | Scras | Sustained release pharmaceutical compositions and the preparation of particles for use therein |
GB9016885D0 (en) * | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
DE4223169C1 (de) * | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
US5569467A (en) * | 1993-05-15 | 1996-10-29 | Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) | Process for the preparation of microballs and microballs thus obtained |
DE19617137C1 (de) * | 1996-04-29 | 1997-02-27 | Henkel Kgaa | Verwendung von Copolymerestern für die Herstellung von Mikrosphären |
US5945128A (en) * | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
FR2756493B1 (fr) * | 1996-12-02 | 2001-04-13 | Delab | Dispositif d'administration locale de formulations solides ou semi-solides |
US20020111603A1 (en) * | 1996-12-02 | 2002-08-15 | Societe De Conseils De Recherches Et D'application | Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process |
IT1304152B1 (it) * | 1998-12-10 | 2001-03-08 | Mediolanum Farmaceutici Srl | Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato |
CA2435415A1 (en) * | 2001-01-26 | 2002-08-01 | Debio Recherche Pharmaceutique S.A. | Microparticles of biodegradable polymer encapsulating a biologically active substance |
GB0122113D0 (en) * | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Composition |
-
2004
- 2004-02-05 FR FR0401109A patent/FR2865938B1/fr not_active Expired - Fee Related
-
2005
- 2005-01-27 TW TW094102537A patent/TWI399224B/zh not_active IP Right Cessation
- 2005-02-04 MX MXPA06008617A patent/MXPA06008617A/es active IP Right Grant
- 2005-02-04 CN CN2005800035442A patent/CN1913924B/zh not_active Expired - Fee Related
- 2005-02-04 EP EP05717551A patent/EP1722820A1/fr not_active Withdrawn
- 2005-02-04 CA CA002554870A patent/CA2554870A1/fr not_active Abandoned
- 2005-02-04 AR ARP050100422A patent/AR047797A1/es not_active Application Discontinuation
- 2005-02-04 WO PCT/FR2005/000248 patent/WO2005082418A1/fr active Application Filing
- 2005-02-04 BR BRPI0507326-0A patent/BRPI0507326A/pt not_active IP Right Cessation
- 2005-02-04 RU RU2006131705/15A patent/RU2399384C2/ru not_active IP Right Cessation
- 2005-02-04 JP JP2006551883A patent/JP2007520533A/ja active Pending
-
2006
- 2006-07-11 IL IL176786A patent/IL176786A0/en unknown
- 2006-08-07 US US11/499,777 patent/US20070031500A1/en not_active Abandoned
-
2007
- 2007-08-13 HK HK07108741.8A patent/HK1101127A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2007520533A (ja) | 2007-07-26 |
FR2865938B1 (fr) | 2006-06-02 |
TWI399224B (zh) | 2013-06-21 |
CN1913924B (zh) | 2011-11-09 |
US20070031500A1 (en) | 2007-02-08 |
EP1722820A1 (fr) | 2006-11-22 |
RU2399384C2 (ru) | 2010-09-20 |
MXPA06008617A (es) | 2006-08-28 |
CN1913924A (zh) | 2007-02-14 |
RU2006131705A (ru) | 2008-03-10 |
IL176786A0 (en) | 2006-10-31 |
HK1101127A1 (en) | 2007-10-12 |
BRPI0507326A (pt) | 2007-07-03 |
CA2554870A1 (fr) | 2005-09-09 |
FR2865938A1 (fr) | 2005-08-12 |
TW200528143A (en) | 2005-09-01 |
WO2005082418A1 (fr) | 2005-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR047797A1 (es) | Formulacion solida de liberacion sostenida que comprende acetato de triptorelina | |
EA201401348A1 (ru) | Технология приготовления имплантируемой формы палиперидона | |
CY1124369T1 (el) | Συνθεση εμφυτευματος ρισπεριδονης ή/και παλιπεριδονης | |
UY25765A1 (es) | Formulaciones farmacéuticas de liberación controlada | |
ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
NZ586221A (en) | Dosing regimen associated with long acting injectable paliperidone esters | |
ECSP13012474A (es) | Forma de dosificación resistente a manipulación que comprende una sal inorgánica | |
HRP20110169T1 (hr) | Upotreba [d-meala]3-[etval]4-ciklosporina za liječenje infekcija hepatitisom c | |
AR068185A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
AR039744A1 (es) | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada | |
RU2011110765A (ru) | Фармацевтическая композиция энтакапона или его солей пролонгрированного высвобождения | |
CO6670590A2 (es) | Forma de dosificación reistente a alteración que comprende un polímero aniónico | |
MX345291B (es) | Microgranulos y microtabletas resistentes a uso inapropiado. | |
CY1109425T1 (el) | Φαρμακευτικες συνθεσεις για τη χορηγηση με ελεγχομενη αποδεσμευση βιολογικα δραστικων ενωσεων | |
RU2009111391A (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ чГР, ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ | |
AR076722A1 (es) | Conjunto para un dispositivo para l a entrega de farmacos y dispositivo para la entrega de farmacos | |
AR062659A1 (es) | Composicion de liberacion sostenida de levodopa y metodo para su uso | |
JP2012517449A5 (es) | ||
AR061790A1 (es) | Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento | |
HRP20161197T1 (hr) | 24-norudca za liječenje autoimunog hepatitisa | |
BRPI0510738A (pt) | métodos de tratar doenças com copolìmeros aleatórios | |
RU2006137349A (ru) | Композиции продолжительного действия на основе налтрексона | |
WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
JP2016512247A5 (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |